Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.
Pierre DeltenreEric TrépoNaoto FujiwaraNicolas GoossensAstrid MarotMargaux DuboisLaurent SpahrJean HenrionChristophe MorenoYujin HoshidaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Both gs-MELD score and alcohol consumption drive AH long-term prognosis. The gs-MELD score may guide the development of molecularly targeted therapies in AH.